Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review
Arthritis Care & Research · 2023-11 · 75 (11) · 2306-2315
DOI: 10.1002/acr.25141 ↗Kurz gefasst
Scoping Review in der Zeitschrift Arthritis Care & Research, online erschienen am 12.06.2023. Verfasst von Jiun Ming Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of South Australia, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Methotrexate (MTX) is effective in controlling disease activity in rheumatoid arthritis (RA). Parenteral MTX may have benefits over oral MTX, but it is rarely used in practice. To better understand this low usage rate, it is necessary to explore the barriers and enablers of therapy from the perspective of RA patients. The objectives of this scoping review were to describe RA patients’ perspectives on the barriers and enablers in the use of parenteral MTX and to identify the research gaps in this field.
Methods
The search was performed in Medline, Embase, Scopus, and Cochrane Library from inception to May 2021. Data synthesis was conducted using the Theoretical Framework of Acceptability. This scoping review included any type of study that explored the use of parenteral MTX by adult RA patients from the patients’ perspective, written in English.
Results
Fifteen studies were included; findings related to the constructs “affective attitude,” “burden,” “intervention coherence,” and “self‐efficacy” were explored the most, while some were rarely (“opportunity cost” and “perceived effectiveness”) or not (“ethicality”) reported. RA patients were generally satisfied with MTX injections (“affective attitude”). From the burden construct, the requirement for dexterity for administering MTX by injection was considered a barrier, whereas the lack of significant pain from MTX injection was considered an enabler.
Conclusion
The findings suggested that patients generally preferred parenteral MTX formulations with attributes that facilitate self‐administration. However, much of the identified research focused on prefilled pen devices, and significant gaps were identified, such as a lack of qualitative research. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of South Australia, Adelaide, South Australia, Australia.
- Monash University, Parkville, Victoria, Australia, and University of South Australia, Adelaide, Australia.
- Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Jiun Ming Tan, Emily Reeve, Lauren Fraser, Susanna M Proudman, Michael D Wiese
Zitieren
APA
Tan, J. M., Reeve, E., Fraser, L., Proudman, S. M., & Wiese, M. D. (2023). Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care & Research, 75(11), 2306-2315. https://doi.org/10.1002/acr.25141
Vancouver
Tan JM, Reeve E, Fraser L, Proudman SM, Wiese MD. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care & Research. 2023;75(11):2306-2315. doi:10.1002/acr.25141
BibTeX
@article{Tan2023,
author = {Tan, Jiun Ming and Reeve, Emily and Fraser, Lauren and Proudman, Susanna M and Wiese, Michael D},
title = {Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review},
journal = {Arthritis Care & Research},
year = {2023},
volume = {75},
number = {11},
pages = {2306--2315},
doi = {10.1002/acr.25141}
}
EUVIMED